SP1 and breast carcinoma: Elevated Sp1 levels have been reported in multiple cancers, including gastric cancer (GC), ovarian cancer, pancreatic cancer, hepatocellular carcinoma, glioblastoma, lung cancer, breast cancer, and colorectal cancer (CRC).